Role of poly(ADP-ribose) glycohydrolase silencing in DNA hypomethylation induced by benzo(a)pyrene

Biochemical and Biophysical Research Communications

Volumn 452, Issue 3, 2014, Pages 708-714

  Huang, Haiyan ^a   Hu, Gonghua ^a,b   Cai, Jianfeng ^a   Xia, Bo ^a   Liu, Jianjun ^a   Li, Xuan ^a   Gao, Wei ^a   Zhang, Jianqing ^a   Liu, Yinpin ^a   Zhuang, Zhixiong ^a  

^a SHENZHEN CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b GANNAN MEDICAL UNIVERSITY   (China)

Author keywords

Benzo(a)pyrene; DNA methylation; Human bronchial epithelial (16HBE) cells; Poly(ADP ribose) glycohydrolase; Poly(ADP ribosyl)ation

Indexed keywords

BENZO[A]PYRENE; DNA METHYLTRANSFERASE; DNA METHYLTRANSFERASE 1; GLYCOSIDASE; POLY(ADENOSINE DIPHOSPHATE RIBOSE); POLY(ADENOSINE DIPHOSPHATE RIBOSE)GLYCOHYDROLASE; UNCLASSIFIED DRUG; CARCINOGEN; DNA (CYTOSINE 5) METHYLTRANSFERASE; DNA (CYTOSINE-5-)-METHYLTRANSFERASE 1; POLY ADP-RIBOSE GLYCOHYDROLASE; SMALL INTERFERING RNA;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ARTICLE; BRONCHUS MUCOSA; CONTROLLED STUDY; DNA METHYLATION; ENZYME ACTIVITY; EPITHELIUM CELL; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; NULL CELL; PROTEIN EXPRESSION; PROTEIN INTERACTION; ANTAGONISTS AND INHIBITORS; BRONCHUS; CELL ENGINEERING; CELL LINE; DOSE RESPONSE; DRUG EFFECTS; ENZYMOLOGY; GENETICS; METABOLISM; PATHOLOGY; PROTEIN PROCESSING; TOXICITY;

BENZO(A)PYRENE; BRONCHI; CARCINOGENS; CELL ENGINEERING; CELL LINE; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; GLYCOSIDE HYDROLASES; HUMANS; POLY ADENOSINE DIPHOSPHATE RIBOSE; PROTEIN PROCESSING, POST-TRANSLATIONAL; RNA, SMALL INTERFERING;

EID: 84907512200     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.08.146     Document Type: Article

References (41)

1. D. Rodenhiser, and M. Mann Epigenetics and human disease: translating basic biology into clinical applications CMAJ 174 2006 341 348
2. A.D. Goldberg, C.D. Allis, and E. Bernstein Epigenetics: a landscape takes shape Cell 128 2007 635 638
3. Y. Li, and T.O. Tollefsbol Impact on DNA methylation in cancer prevention and therapy by bioactive dietary components Curr. Med. Chem. 17 2010 2141 2151
4. P.A. Jones, and S.B. Baylin The fundamental role of epigenetic events in cancer Nat. Rev. Genet. 3 2002 415 428
5. R. Krishnakumar, M.J. Gamble, K.M. Frizzell, J.G. Berrocal, M. Kininis, and W.L. Kraus Reciprocal binding of PARP-1 and histone H1 at promoters specifies transcriptional outcomes Science 319 2008 819 821
6. M. Rouleau, R.A. Aubin, and G.G. Poirier Poly(ADP-ribosyl)ated chromatin domains: access granted J. Cell Sci. 117 2004 815 825
7. A. Tulin, and A. Spradling Chromatin loosening by poly(ADP)-ribose polymerase (PARP) at Drosophila puff loci Science 299 2003 560 562
8. J.T. Heeres, and P.J. Hergenrother Poly(ADP-ribose) makes a date with death Curr. Opin. Chem. Biol. 11 2007 644 653
9. J. Diefenbach, and A. Burkle Introduction to poly(ADPribose) metabolism Cell. Mol. Life Sci. 62 2005 721 730
10. L. Davidovic, M. Vodenicharov, E.B. Affar, and G.G. Poirier Importance of poly(ADP-ribose) glycohydrolase in the control of poly (ADP-ribose) metabolism Exp. Cell Res. 268 2001 7 13
11. M. Rouleau, A. Patel, M.J. Hendzel, S.H. Kaufmann, and G.G. Poirier PARP inhibition: PARP1 and beyond Nature 10 2010 293 301
12. G. Zardo, S. Marenzi, M. Perilli, and P. Caiafa Inhibition of poly(ADP-ribosyl)ation introduces an anomalous methylation pattern in transfected foreign DNA FASEB J. 13 1999 1518 1522
13. T. Guastafierro, B. Cecchinelli, M. Zampieri, A. Reale, G. Riggio, O. Sthandier, G. Zupi, L. Calabrese, and P. Caiafa CCCTC-binding factor activates PARP-1 affecting DNA methylation machinery J. Biol. Chem. 283 2008 21873 21880
14. A. Reale, G.D. Matteis, G. Galleazzi, M. Zampieri, and P. Caiafa Modulation of DNMT1 activity by ADP-ribose polymers Oncogene 24 2005 13 19
15. L. Umannová, M. Machala, J. Topinka, J. Schmuczerová, P. Krčmář, J. Neča, K. Sujanová, A. Kozubík, and J. Vondráček Benzo[a]pyrene and tumor necrosis factor-α coordinately increase genotoxic damage and the production of proinflammatory mediators in alveolar epithelial type II cells Toxicol. Lett. 206 2 2011 121 129
16. H. Hamouchene, V.M. Arlt, I. Giddings, and D.H. Phillips Influence of cell cycle on responses of MCF-7 cells to benzo[a]pyrene BMC Genomics 12 2011 333
17. C. Yan, W. Wu, H. Li, G. Zhang, P.J. Duerksen-Hughes, X. Zhu, and J. Yang Benzo[a]pyrene treatment leads to changes in nuclear protein expression and alternative splicing Mutat. Res. 686 2010 47 56
18. H.Y. Huang, J.F. Cai, Q.C. Liu, G.H. Hu, B. Xia, J.Y. Mao, D.S. Wu, J.J. Liu, and Z.X. Zhuang Role of poly(ADP-ribose) glycohydrolase in the regulation of cell fate in response to benzo(a)pyrene Exp. Cell Res. 318 2012 682 690
19. A.M. Giraldo, J.W. Lynn, M.N. Purpera, R.A. Godke, and K.R. Bondioli DNA methylation and histone acetylation patterns in cultured bovine fibroblasts for nuclear transfer Mol. Reprod. Dev. 74 2007 1514 1524
20. X. Feng, and D.W. Koh Roles of poly(ADP-ribose) glycohydrolase in DNA damage and apoptosis Int. Rev. Cell Mol. Biol. 304 2013 227 281
21. M. Miwa, and M. Masutani PolyADP-ribosylation and cancer Cancer Sci. 98 2007 1528 1535
22. P.A. Jones, and S.B. Baylin The fundamental role of epigenetic events in cancer Nat. Rev. Genet. 3 2002 415 428
23. P.A. Jones DNA methylation and cancer Oncogene 21 2002 5358 5360
24. R. Krishnakumar, and W.L. Kraus The PARP side of the nucleus: molecular actions, physiological outcomes, and clinical targets Mol. Cell 39 2010 8 24
25. D. Quénet, R. El Ramy, V. Schreiber, and F. Dantzer The role of poly(ADPribosyl)ation in epigenetic events Int. J. Biochem. Cell Biol. 41 2009 60 65
26. P. Caiafa, T. Guastafierro, and M. Zampieri Epigenetics: poly(ADP-ribosyl)ation of PARP-1 regulates genomic methylation patterns FASEB J. 23 2009 672 678
27. S. Baylin DNA methylation and epigenetic mechanisms of carcinogenesis Dev. Biol. (Basel) 106 2001 85 87
28. S.B. Baylin, M. Esteller, M.R. Rountree, K.E. Bachman, K. Schuebel, and J.G. Herman Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer Hum. Mol. Genet. 10 2001 687 692
29. Q. Lu, X. Qiu, N. Hu, H. Wen, Y. Su, and B.C. Richardson Epigenetics, disease, and therapeutic interventions Ageing Res. Rev. 5 2006 449 467
30. T. Chen, Y. Ueda, J.E. Dodge, Z. Wang, and E. Li Establishment and maintenance of genomic methylation patterns in mouse embryonic stem cells by Dnmt3a and Dnmt3b Mol. Cell. Biol. 23 2003 5594 5605
31. I. Rhee, K.E. Bachman, B.H. Park, K.W. Jair, R.W. Yen, K.E. Schuebel, H. Cui, A.P. Feinberg, C. Lengauer, K.W. Kinzler, S.B. Baylin, and B. Vogelstein DNMT1 and DNMT3b cooperate to silence genes in human cancer cells Nature 416 2002 552 556
32. M. Szyf, D.J. Knox, S. Milutinovic, A.D. Slack, and F.D. Araujo How does DNA methyltransferase cause oncogenic transformation? Ann. N. Y. Acad. Sci. 910 2000 156 174
33. Y. Saito, Y. Kanai, T. Nakagawa, M. Sakamoto, H. Saito, H. Ishii, and S. Hirohashi Increased protein expression of DNA methyltransferase (DNMT) 1 is significantly correlated with the malignant potential and poor prognosis of human hepatocellular carcinomas Int. J. Cancer 105 2003 527 532
34. S. Mizuno, T. Chijiwa, T. Okamura, K. Akashi, Y. Fukumaki, Y. Niho, and H. Sasaki Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia Blood 97 2001 1172 1179
35. K.D. Robertson, E. Uzvolgyi, G. Liang, C. Talmadge, J. Sumegi, F.A. Gonzales, and P.A. Jones The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors Nucleic Acids Res. 27 1999 2291 2298
36. D.T. Butcher, and D.I. Rodenhiser Epigenetic inactivation of BRCA1 is associated with aberrant expression of CTCF and DNA methyltransferase (DNMT3B) in some sporadic breast tumours Eur. J. Cancer 43 2007 210 219
37. J.D. Roll, A.G. Rivenbark, W.D. Jones, and W.B. Coleman DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines Mol. Cancer 7 2008 15
38. H. Shen, L. Wang, M.R. Spitz, W.K. Hong, L. Mao, and Q. Wei A novel polymorphism in human cytosine DNA-methyltransferase-3B promoter is associated with an increased risk of lung cancer Cancer Res. 62 2002 4992 4995
39. S.J. Lee, H.S. Jeon, J.S. Jang, S.H. Park, G.Y. Lee, B.H. Lee, C.H. Kim, Y.M. Kang, W.K. Lee, S. Kam, R.W. Park, I.S. Kim, Y.L. Cho, T.H. Jung, and J.Y. Park DNMT3B polymorphisms and risk of primary lung cancer Carcinogenesis 26 2005 403 409
40. I. Girault, S. Tozlu, R. Lidereau, and I. Bièche Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas Clin. Cancer Res. 9 2003 4415 4422
41. O.Y. Mian, S.Z. Wang, S.Z. Zhu, M.N. Gnanapragasam, L. Graham, H.D. Bear, and G.D. Ginder Methyl-binding domain protein 2-dependent proliferation and survival of breast cancer cells Mol. Cancer Res. 9 2011 1152 1162